Price$10.72-0.56 (-4.96%)
01:30 PM07:45 PM
News · 26 weeks91+20%
2026-01-182026-07-12
Mix6790d
- Insider40(60%)
- SEC Filings17(25%)
- Other5(7%)
- Earnings2(3%)
- Leadership2(3%)
- Dividends1(1%)
Latest news
25 items- INSIDERSEC Form 4 filed by Director Amin Ahmed Salman4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by Director Gajial Muhammad Omer4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERNew insider Gajial Muhammad Omer claimed no ownership of stock in the company (SEC Form 3)3 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERNew insider Amin Ahmed Salman claimed no ownership of stock in the company (SEC Form 3)3 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & Chief Financial Officer Bezerra Eduardo Guarita4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP and President of CSCI Khoury Roberto4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & CBDO Ball David4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP, General Counsel & Sec. Atkinson Charles4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP, Supply, Ops, Strategy Winterman Matthew John4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP & CHRO Willis Robert4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by EVP and CSO Lennox Abigail4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDEREVP, Supply, Ops, Strategy Winterman Matthew John exercised 17,503 units of Ordinary Shares at a strike of $10.52 and covered exercise/tax liability with 9,138 units of Ordinary Shares (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDEREVP and President of CSCI Khoury Roberto exercised 737 units of Ordinary Shares at a strike of $10.52 and covered exercise/tax liability with 385 units of Ordinary Shares, increasing direct ownership by 3% to 14,113 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- SECAmendment: Perrigo Company plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - PERRIGO Co plc (0001585364) (Filer)
- SECPerrigo Company plc filed SEC Form 8-K: Leadership Update8-K - PERRIGO Co plc (0001585364) (Filer)
- SECPerrigo Company plc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - PERRIGO Co plc (0001585364) (Filer)
- PRPerrigo Announces Appointment of Two New Independent Directors to BoardDUBLIN, June 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo"), a leading provider of consumer health products, today announced that its Board of Directors has appointed Salman Amin and Omer Gajial as independent directors, effective June 30, 2026. "We are pleased to welcome Salman and Omer to Perrigo's Board," said Orlando D. Ashford, Chair of Perrigo's Board of Directors. "Both bring deep experience across consumer products, retail, and digital transformation, along with a strong track record of driving growth and operational excellence. Their perspective will be valuable as we continue to advance Perrigo's
- SECSEC Form 11-K filed by Perrigo Company plc11-K - PERRIGO Co plc (0001585364) (Filer)
- INSIDERDirector Parker Geoffrey M. exercised 976 units of Ordinary Shares at a strike of $10.99 and covered exercise/tax liability with 469 units of Ordinary Shares, increasing direct ownership by 2% to 33,217 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERSEC Form 4 filed by Interim President and CEO Manzone Albert4 - PERRIGO Co plc (0001585364) (Issuer)
- INSIDERDirector Alford Bradley A exercised 976 units of Ordinary Shares at a strike of $10.99 and covered exercise/tax liability with 469 units of Ordinary Shares, increasing direct ownership by 1% to 45,465 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- SECSEC Form SD filed by Perrigo Company plcSD - PERRIGO Co plc (0001585364) (Filer)
- INSIDERFormer CEO and director Lockwood-Taylor Patrick exercised 25,230 units of Ordinary Shares at a strike of $10.83 and covered exercise/tax liability with 12,906 units of Ordinary Shares, increasing direct ownership by 11% to 123,170 units (SEC Form 4)4 - PERRIGO Co plc (0001585364) (Issuer)
- SECPerrigo Company plc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - PERRIGO Co plc (0001585364) (Filer)
- PRPerrigo Announces Leadership TransitionAlbert A. Manzone Appointed Interim President and CEOPatrick Lockwood-Taylor Resigns as President and CEO and as a Member of the BoardDUBLIN, June 8, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that its Board of Directors has appointed Albert A. Manzone, a member of the Company's Board, as Interim President and Chief Executive Officer, effective immediately. The Board has initiated a comprehensive search process to identify a permanent successor. Patrick Lockwood-Taylor has resigned as President and CEO, and as a member of
PRGO FAQ
7 questionsWhat does Perrigo Company plc do?
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and...Where does PRGO stock trade?
Perrigo Company plc (PRGO) is listed on NYSE.What sector and industry is PRGO in?
Perrigo Company plc operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.Does PRGO pay a dividend?
PRGO's most recent ex-dividend date was 2026-05-29 with a cash dividend of $0.22 per share. No future ex-date is on file yet.What are analysts saying about PRGO?
Perrigo Company plc has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral with a $2000.00 price target on 2025-11-06. Recent price targets range from $2000.00 to $4900.00.What companies are similar to PRGO?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare PRGO side-by-side with any of them on Quantisnow.How can I track PRGO on Quantisnow?
Quantisnow aggregates Perrigo Company plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRGO to receive live email and push alerts on every new disclosure.